Parkway Life Real Estate Investment Trust (C2PU.SI)
Parkway Life Real Estate Investment Trust operates in the REIT - Healthcare Facilities industry of the Real Estate sector, headquartered in Singapore, CE, SG. The stock last traded at $4.00, down 0.50% on the session, giving a market capitalisation of $2.61B. Its beta of 0.45 implies it has historically moved less than the broad market.
Parkway Life Real Estate Investment Trust (PLife REIT) is recognized as one of Asia's foremost publicly listed healthcare REITs based on its significant asset holdings. The trust's investment strategy focuses on acquiring income-generating real estate and associated assets predominantly utilized for healthcare and related services. This comprehensive mandate covers hospitals, various medical facilities, and properties supporting healthcare research, education, and the production or warehousing of pharmaceuticals, medical goods, and devices. As of December 31, 2020, PLife REIT managed a robust and geographically diversified portfolio comprising 54 properties across the Asia Pacific region, with a total valuation of approximately S$2.02 billion. Its Singaporean assets include the largest collection of strategically located private hospitals: Mount Elizabeth Hospital, Gleneagles Hospital, and Parkway East Hospital. Furthermore, its Japanese holdings encompass 50 high-quality nursing home and care facilities situated in various prefectures. The trust also possesses strata-titled units within the MOB Specialist Clinics in Kuala Lumpur, Malaysia.
Parkway Life Real Estate Investment Trust is most often compared with the following Real Estate names: